Table of Contents
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Protein Expression Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing demand for protein biologics
3.2.1.2. Increasing R&D in pharmaceutical and biopharmaceutical industries
3.2.1.3. Growing adoption of recombinant-based protein expression
3.2.1.4. Availability of funding for protein-based research
3.2.2. Restraints
3.2.2.1. High cost of protein expression reagents and instruments
3.2.2.2. Increasing consolidation and high barriers for new entrants
3.2.3. Opportunities
3.2.3.1. Emergence of microfluidics
3.2.3.2. Emerging economies offering significant growth potential
3.2.4. Challenges
3.2.4.1. Undesired post-translational modifications and purification
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Protein Expression Market Overview
4.1. Market Size & Forecast by Value, 2019-2029
4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
4.2.1. By System Type
4.2.1.1. Mammalian Cell Expression Systems
4.2.1.2. Prokaryotic expression systems
4.2.1.3. Insect cell expression systems
4.2.1.4. Yeast expression systems
4.2.1.5. Cell-free expression systems
4.2.1.6. Algal-based expression systems
4.2.2. By Application
4.2.2.1. Therapeutic
4.2.2.2. Research
4.2.2.3. Industrial
4.2.3. By End User
4.2.3.1. Pharmaceutical and Biotechnology companies
4.2.3.2. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)
4.2.3.3. Academic Research Institutes
4.2.3.4. Others
4.2.4. By Region
4.2.4.1. North America
4.2.4.2. Europe
4.2.4.3. Asia Pacific (APAC)
4.2.4.4. Latin America (LATAM)
4.2.4.5. Middle East and Africa (MEA)
5. North America Protein Expression Market
5.1. Market Size & Forecast by Value, 2019-2029
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By System Type
5.2.2. By Application
5.2.3. By End User
5.2.4. By Country
5.2.4.1. US
5.2.4.1.1. By System Type
5.2.4.1.2. By Application
5.2.4.1.3. By End User
5.2.4.2. Canada
5.2.4.2.1. By System Type
5.2.4.2.2. By Application
5.2.4.2.3. By End User
6. Europe Protein Expression Market
6.1. Market Size & Forecast by Value, 2019-2029
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By System Type
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.2.4.1. Germany
6.2.4.1.1. By System Type
6.2.4.1.2. By Application
6.2.4.1.3. By End User
6.2.4.2. UK
6.2.4.2.1. By System Type
6.2.4.2.2. By Application
6.2.4.2.3. By End User
6.2.4.3. Italy
6.2.4.3.1. By System Type
6.2.4.3.2. By Application
6.2.4.3.3. By End User
6.2.4.4. France
6.2.4.4.1. By System Type
6.2.4.4.2. By Application
6.2.4.4.3. By End User
6.2.4.5. Spain
6.2.4.5.1. By System Type
6.2.4.5.2. By Application
6.2.4.5.3. By End User
6.2.4.6. The Netherlands
6.2.4.6.1. By System Type
6.2.4.6.2. By Application
6.2.4.6.3. By End User
6.2.4.7. Rest of Europe
6.2.4.7.1. By System Type
6.2.4.7.2. By Application
6.2.4.7.3. By End User
7. Asia Pacific Protein Expression Market
7.1. Market Size & Forecast by Value, 2019-2029
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By System Type
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.2.4.1. China
7.2.4.1.1. By System Type
7.2.4.1.2. By Application
7.2.4.1.3. By End User
7.2.4.2. India
7.2.4.2.1. By System Type
7.2.4.2.2. By Application
7.2.4.2.3. By End User
7.2.4.3. Japan
7.2.4.3.1. By System Type
7.2.4.3.2. By Application
7.2.4.3.3. By End User
7.2.4.4. South Korea
7.2.4.4.1. By System Type
7.2.4.4.2. By Application
7.2.4.4.3. By End User
7.2.4.5. Australia & New Zealand
7.2.4.5.1. By System Type
7.2.4.5.2. By Application
7.2.4.5.3. By End User
7.2.4.6. Indonesia
7.2.4.6.1. By System Type
7.2.4.6.2. By Application
7.2.4.6.3. By End User
7.2.4.7. Malaysia
7.2.4.7.1. By System Type
7.2.4.7.2. By Application
7.2.4.7.3. By End User
7.2.4.8. Singapore
7.2.4.8.1. By System Type
7.2.4.8.2. By Application
7.2.4.8.3. By End User
7.2.4.9. Philippines
7.2.4.9.1. By System Type
7.2.4.9.2. By Application
7.2.4.9.3. By End User
7.2.4.10. Vietnam
7.2.4.10.1. By System Type
7.2.4.10.2. By Application
7.2.4.10.3. By End User
7.2.4.11. Rest of APAC
7.2.4.11.1. By System Type
7.2.4.11.2. By Application
7.2.4.11.3. By End User
8. Latin America Protein Expression Market
8.1. Market Size & Forecast by Value, 2019-2029
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By System Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.2.4.1. Brazil
8.2.4.1.1. By System Type
8.2.4.1.2. By Application
8.2.4.1.3. By End User
8.2.4.2. Mexico
8.2.4.2.1. By System Type
8.2.4.2.2. By Application
8.2.4.2.3. By End User
8.2.4.3. Argentina
8.2.4.3.1. By System Type
8.2.4.3.2. By Application
8.2.4.3.3. By End User
8.2.4.4. Peru
8.2.4.4.1. By System Type
8.2.4.4.2. By Application
8.2.4.4.3. By End User
8.2.4.5. Colombia
8.2.4.5.1. By System Type
8.2.4.5.2. By Application
8.2.4.5.3. By End User
8.2.4.6. Rest of LATAM
8.2.4.6.1. By System Type
8.2.4.6.2. By Application
8.2.4.6.3. By End User
9. Middle East & Africa Protein Expression Market
9.1. Market Size & Forecast by Value, 2019-2029
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By System Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Saudi Arabia
9.2.4.1.1. By System Type
9.2.4.1.2. By Application
9.2.4.1.3. By End User
9.2.4.2. UAE
9.2.4.2.1. By System Type
9.2.4.2.2. By Application
9.2.4.2.3. By End User
9.2.4.3. Qatar
9.2.4.3.1. By System Type
9.2.4.3.2. By Application
9.2.4.3.3. By End User
9.2.4.4. Kuwait
9.2.4.4.1. By System Type
9.2.4.4.2. By Application
9.2.4.4.3. By End User
9.2.4.5. South Africa
9.2.4.5.1. By System Type
9.2.4.5.2. By Application
9.2.4.5.3. By End User
9.2.4.6. Nigeria
9.2.4.6.1. By System Type
9.2.4.6.2. By Application
9.2.4.6.3. By End User
9.2.4.7. Algeria
9.2.4.7.1. By System Type
9.2.4.7.2. By Application
9.2.4.7.3. By End User
9.2.4.8. Rest of MEA
9.2.4.8.1. By System Type
9.2.4.8.2. By Application
9.2.4.8.3. By End User
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Protein Expression Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Protein Expression Market
12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
12.1. Thermo Fisher Scientific, Inc.
12.2. Merck KGaA
12.3. GenScript Biotech Corporation
12.4. Agilent Technologies, Inc.
12.5. Takara Bio, Inc.
12.6. Bio-Rad Laboratories, Inc
12.7. Qiagen N.V
12.8. Charles River Laboratories, Inc.
12.9. Danaher Corporation
12.10. Sartorius AG
12.11. Corning Incorporated
12.12. FUJIFILM Irvine Scientific, Inc.
12.13. Lonza Group AG
12.14. Bioneer Corporation
12.15. Promega Corporation
12.16. Oxford Expression Technologies Ltd
12.17. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumption & Limitation